Singapore Wants You!
“The future-friendly city-state has an offer bioscientists can’t refuse: unrestricted research, top-notch equipment, and limitless funds. (Just leave your chewing gum at home.)”
Biotech’s Longer Convalescence
“The biotech sector has fallen, and it doesn’t seem able to get up. “
China: how to seize “commanding point” of biotechnology
“China’s capital investment in the scientific research of life science is far from enough, and the government should create fine environment for the development of biotechnology industry, and mobilize all forces in the society to develop biotechnology and industry…”
Stem-Cell Cash on a Winding Road
They may not be investing in the companies themselves, but venture capitalists haven’t completely abandoned stem-cell work. Instead, they’re contributing through efforts like the California Stem Cell Initiative…
ImClone Hammered as Sales Lag Estimates
Scandal-plagued ImClone Systems may have fallen off the road to recovery.
While the company’s second-quarter earnings beat Wall Street estimates, the stock plunged yesterday on disappointing sales of the company’s key cancer drug.